Can Statin Cause Neuropathy? What You Should Know

If you take a statin and have noticed tingling, burning, or numbness in your feet or hands, you are not imagining it, and you are not alone in asking whether the two are connected. Statins can cause muscle symptoms, and in some people they have been linked to nerve symptoms too, but the evidence for a direct cause-and-effect relationship with neuropathy is far from settled. Peripheral neuropathy has many common causes — diabetes being the most frequent — and sorting out what is actually driving your symptoms matters more than assuming the statin is to blame.

Can Statin Cause Neuropathy?

Statins are not a well-established cause of peripheral neuropathy. The evidence linking them is mixed, and most major reviews have not found a consistent, strong connection.

That said, “not well-established” is not the same as “ruled out.” A small number of observational studies over the years have reported a modest association between statin use and peripheral neuropathy. Observational studies follow people over time and look for patterns — they cannot prove that one thing caused another. People taking statins often have other conditions that independently raise neuropathy risk, including diabetes, older age, and cardiovascular disease. Untangling those threads is genuinely difficult.

What we can say with confidence: if a statin is contributing to nerve symptoms in any given person, it would be an uncommon reaction, not a typical one. Muscle-related side effects are much more commonly reported and better documented than nerve-related ones.

What Is Peripheral Neuropathy and How Does It Develop?

Peripheral neuropathy is damage or dysfunction of the peripheral nerves — the nerves outside your brain and spinal cord that carry signals between your body and your central nervous system.

These nerves do a lot. They carry sensation (touch, temperature, pain), control muscle movement, and regulate automatic functions like blood pressure and digestion. When they are damaged, the symptoms depend heavily on which nerves are affected.

The most common pattern is a “stocking-glove” distribution, meaning symptoms start in the feet and toes and move upward, sometimes later affecting the hands. This happens because the longest nerves are typically affected first. That length-dependent pattern is a hallmark of many neuropathies, including diabetic neuropathy.

Nerve damage usually develops slowly, over months or years, rather than suddenly. The underlying problem is often reduced blood flow to the nerves, direct metabolic injury, or inflammation. In diabetes, for example, chronically high blood sugar damages nerves through multiple pathways. In other cases, the cause is nutritional deficiency, toxicity, immune attack, or genetics.

What Are the Symptoms of Peripheral Neuropathy?

Symptoms vary widely, but certain patterns are common. If you recognize several of these, it is worth discussing with a clinician.

• Numbness or reduced ability to feel pain or temperature, especially in the feet
• Tingling, prickling, or “pins and needles” sensations
• Burning or sharp, stabbing pain, often worse at night
• Extreme sensitivity to touch (even light contact can be painful)
• Weakness or difficulty with balance and coordination
• Feeling as though you are wearing socks when you are not

Some people have predominantly sensory symptoms (numbness, tingling, pain) while others have more weakness. The pattern and progression help clinicians narrow down the cause. Neuropathy that begins suddenly or progresses rapidly is more concerning and warrants prompt evaluation.

How Common Is Statin-Related Neuropathy?

This is where honesty matters. We do not have a reliable number.

Peripheral neuropathy is common in the general population, particularly with age. Estimates vary, but a meaningful proportion of adults over 40 have some degree of neuropathy, most often from diabetes or prediabetes. Because the baseline rate is high, it is statistically difficult to determine how much, if any, additional risk a statin might contribute.

Some reviews have concluded that the evidence does not support a meaningful causal link. Others have suggested a possible small increase in risk with long-term use. The disagreement itself tells you something: the signal is not strong or consistent enough for the medical community to have reached a firm conclusion.

What is not in dispute is that statins reduce the risk of heart attack and stroke in people who need them. That benefit is well established across large randomized trials. Any discussion of neuropathy risk has to be weighed against that benefit — not in isolation.

How Would You Know If a Statin Is the Cause?

You generally cannot know for certain, and neither can your doctor, without a process of elimination.

There is no blood test or scan that says “this neuropathy is from a statin.” Diagnosis of statin-related neuropathy, when it is considered at all, is typically a diagnosis of exclusion — meaning other causes are ruled out first.

Clinicians typically look for the more common culprits before considering a medication link:

• Diabetes and prediabetes — the leading cause of peripheral neuropathy in the US
• Vitamin B12 deficiency — common, especially with age or certain medications
• Alcohol use — a well-known cause of nerve damage
• Thyroid disease — hypothyroidism can cause neuropathy
• Kidney disease — can lead to nerve damage through toxin buildup
• Other medications — including certain chemotherapy drugs
• Genetic conditions — such as Charcot-Marie-Tooth disease

If all of those are excluded and symptoms began or worsened after starting a statin, a trial discontinuation may be considered. This should only be done with your prescribing clinician’s guidance — never on your own, especially if you have established heart disease.

What Should You Do If You Think Your Statin Is Causing Nerve Symptoms?

Talk to the clinician who prescribed it. Do not stop the medication on your own.

Stopping a statin abruptly without medical guidance can be dangerous if you have established cardiovascular disease. The conversation should be about whether the symptoms are likely related, what alternatives exist, and how to manage your cardiovascular risk either way.

Options your clinician might consider include:

• Switching to a different statin
• Lowering the dose
• Trialing a non-statin cholesterol-lowering medication
• Investigating other causes of neuropathy more thoroughly

None of these decisions should be made in a vacuum. The right choice depends on your personal cardiovascular risk, your symptom severity, and what other causes have been ruled out.

What Else Could Be Causing Your Nerve Symptoms?

Most neuropathy has nothing to do with statins. Diabetes and prediabetes account for a large share of cases in the US. Vitamin B12 deficiency is another common and often overlooked cause, particularly in older adults and people taking metformin or long-term acid-reducing medications.

Alcohol-related neuropathy is also common and frequently underrecognized. And a significant number of neuropathies are classified as idiopathic — meaning no specific cause is ever identified, even after thorough evaluation. That is frustrating, but it is the reality of how these conditions sometimes present.

If you are taking a statin and have neuropathy, the most useful next step is a proper workup for the common causes. That is more likely to give you actionable answers than focusing solely on the statin.

Is It Safe to Keep Taking Your Statin?

For most people, yes. The cardiovascular benefits of statins are well established, and the evidence for a meaningful neuropathy risk is weak.

That does not mean your symptoms do not matter. They do. But the decision to continue or stop should be based on a full picture: your cardiovascular risk, the severity and impact of your nerve symptoms, and whether other causes have been investigated.

If you have concerns, bring them to your clinician. Ask direct questions. Ask what else could be causing your symptoms. Ask what your options are if the statin is suspected. A good clinician will take those questions seriously.